Coenzyme Q10 in Adult-Onset Ataxia

Safety and Tolerability of Coenzyme Q10 in Adult-Onset Sporadic Spinocerebellar Ataxia

NCT00957216•The University of Texas Medical Branch, Galveston

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Sporadic Ataxia

Interventions

Placebo (sugar pill)

Coenzyme Q10

Locations

United States

Locations (1)

The Universtity of Texas, Galveston

Galveston, Texas, United States

Key Dates

Start Date

April 1, 2008

Primary Completion Date

August 1, 2009

Completion Date

August 1, 2009

Last Updated

July 11, 2018

Sponsors

Lead Sponsor

The University of Texas Medical Branch, Galveston

Collaborators

University of Florida

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 11, 2018Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions